SurModics to Attend Piper Jaffray's 23rd Annual Health Care Conference on November 29
The presentation will be available via webcast by visiting the investor relations portion of the Company's website at www.surmodics.com on the day of the Conference and clicking the webcast icon. In addition, the Conference audio and slide presentation will be archived on the Company's website following the meeting.
SurModics’ vision is to extend and improve the lives of patients through
technology innovation. The Company partners with the world’s foremost
medical device, pharmaceutical and life science companies to develop and
commercialize innovative products that result in improved diagnosis and
treatment for patients. Core offerings include: surface modification
coating technologies that impart lubricity, prohealing, and
biocompatibility capabilities; and components for in vitro diagnostic
test kits and specialized surfaces for cell culture and microarrays.
Timothy Arens, Vice President of Finance and interim Chief Financial Officer